Our in vivo data further suggest that intraovarian injection of BM-hMSC stimulates BMP2 gene expression and suppresses androgen-synthesizing gene CYP17A1 expression in the PCOS mouse ovary. Here, BMP2 is linked to polycystic ovary syndrome.